All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Orris Root Extract | NCIT_C107340 | [The oil extracted from the roots of Iris germanica, Iris florentina, and Iris pallida. Orris root oil is used as a perfume ingredient and as an ingredient in gin.] |
| Palmarosa Oil | NCIT_C107341 | [The essential oil of Cymbopogon martini. Palmarosa oil is used in treatments for the skin, nervous, and digestive systems.] |
| Parsley Seed Oil | NCIT_C107342 | [The oil extracted from the seeds of Petroselinum sativum. Parsley seed oil is used primarily for the treatment of digestive issues.] |
| Pelargonium capitatum Oil | NCIT_C107343 | [The essential oil of Pelargonium capitatum. Pelargonium capitatum oil is used for its aromatic properties and as an ingredient in skincare preparations.] |
| Pelargonium odoratissimum Oil | NCIT_C107344 | [The essential oil of Pelargonium odoratissimum. Pelargonium odoratissimum oil is used for its aromatic properties and as an ingredient in skincare preparations.] |
| Lodoxamide Tromethamine | NCIT_C29160 | [The tromethamide salt form of lodoxamide, a synthetic mast cell stabilizing compound with anti-inflammatory activity. Upon administration to the eye, lodoxamide tromethamide inhibits type I immediate hypersensitivity reaction by preventing the antigen-stimulated calcium influx into mast cells, thereby inhibiting release of histamine. Lodoxamide tromethamide also prevents the release of slow-reacting substances of anaphylaxis (SRS-A) and inhibits eosinophil chemotaxis.] |
| Arm Name | NCIT_C93729 | [A non-unique textual identifier for the arm.] |
| Lomotrex | NCIT_C29161 | |
| Loratadine | NCIT_C29162 | [A piperidine histamine H1-receptor antagonist with anti-allergic properties and without sedative effects. Loratadine blocks the H1 histamine receptor and prevents the symptoms that are caused by histamine activity on capillaries, bronchial smooth muscle, and gastrointestinal smooth muscle, including vasodilatation, increased capillary permeability, bronchoconstriction, and spasmodic contraction of gastrointestinal smooth muscle. Loratadine does not cross the blood-brain barrier and does not cause central nervous system effects.] |
| Loratadine/Pseudoephedrine | NCIT_C29163 | [An oral combination preparation containing the antihistamine loratidine and the indirect-acting sympathicomimetic agent pseudoephedrine, with anti-allergic and decongestant activities. Loratadine, a piperidine, blocks the H1-receptor thereby preventing the symptoms that are caused by histamine activity on capillaries, bronchial smooth muscle, and gastrointestinal smooth muscle, including vasodilatation, increased capillary permeability, bronchoconstriction, and spasmodic contraction of gastrointestinal smooth muscle. Pseudoephedrine displaces norepinephrine from storage vesicles in presynaptic neurons, thereby releasing norepinephrine into the neuronal synapses where it stimulates primarily alpha-adrenergic receptors in the nasal mucosa, thereby producing vasoconstriction, reduces swelling of nasal tissues and decreasing nasal and sinus congestion.] |
| Amino-Terminal Amino Acid | NCIT_C54120 | [The amino acid residing in the first position of a protein or peptide.] |
| Protein Structure | NCIT_C13303 | [The amino acids and their 3-D arrangement in constituting a protein.] |
| Lorcet | NCIT_C29164 | |
| Carboxy-Terminal Amino Acid | NCIT_C54121 | [The amino acid residing in the last position of a protein or peptide.] |
| Losartan Potassium | NCIT_C29165 | [The potassium salt of losartan, a non-peptide angiotensin II receptor antagonist with antihypertensive activity. Losartan selectively and competitively binds to the angiotensin II receptor (type AT1) and blocks the binding of angiotensin II to the receptor, thus promoting vasodilatation and counteracting the effects of aldosterone. Converted from angiotensin I by angiotensin-converting enzyme (ACE), angiotensin II stimulates the adrenal cortex to synthesize and secrete aldosterone, decreasing sodium excretion and increasing potassium excretion, and acts as a vasoconstrictor in vascular smooth muscle.] |
| Cytoplasmic Hyaline Globules Present | NCIT_C54122 | |
| Cytoplasmic Alteration | NCIT_C154895 | [A microscopic finding indicating the presence of intracytoplasmic changes in reactive, atypical, dysplastic, or neoplastic cells.] |
| Losartan/Hydrochlorothiazide | NCIT_C29166 | [A combination preparation of a synthetic angiotensin II antagonist and a diuretic thiazide, with antihypertensive activity. Losartan, and its metabolite, selectively and competitively block the binding of angiotensin II to the angiotensin II (AT1) receptor. As a result, angiotensin II-AT1 mediated physiological effects such as vasoconstriction and stimulation of aldosterone synthesis and secretion, which regulates extracellular sodium concentration, are blocked. Hydrochlorothiazide inhibits electrolytes reabsorption via binding to Na-Cl cotransporter on the renal distal tubular, thereby increasing excretion of sodium, potassium, chloride, bicarbonate and water. Both agents lead to a reduction in blood pressure.] |
| Sinusoidal Growth Pattern | NCIT_C54123 | |
| Emulsion Dosage Form | NCIT_C42913 | [A semi-solid composed of at least two immiscible liquids, one of which is dispersed as droplets within the other liquid, and stabilized with one or more emulsifying agents.] |